Lawrence Otto Klein, CBO & COO at CRISPR Therapeutics AG (CRSP), sold 49,318 shares at $60.38 ($3.0M) on 2020-05-11, disclosed to the SEC on 2020-05-13.
Open-market sale of $3.0M CRSP by CBO & COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.38 | 24,318 | $1.5M | 49.3% |
| 2 | $60.38 | 24,318 | $1.5M | 49.3% |
| 3 | $61.07 | 682 | $42K | 1.4% |
| Total | $60.39 avg | 49,318 | $3.0M | 100% |
| Filing → |
| ORKA | SELL | 2026-09-01 | $6.9M | — | Filing → |
| ORKA | SELL | 2026-06-15 | $120K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $71K | — | Filing → |